Evaluation of the risk of developing hepatocellular carcinoma in chronic Hepatitis C patients receiving antiviral treatment

Introduction: Chronic HC leads to the development of liver cirrhosis (LC) and hepatocellular carcinoma (HCC). The treatment of chronic HC with DAAs reduces mortality from LC and HCC. The study aimed to investigate the serological markers specific to HCC (PIVKA-II and AFP) in patients with chronic H...

詳細記述

書誌詳細

出版年:	Journal of Infection in Developing Countries
主要な著者:	Sona Sargsyan, Hripsime Magdesieva, Tsoghik Navoyan, Aregnaz Mkhitaryan, Lusine Atoyan, Violeta Sargsyan, Hayk Harutyunyan, Vahe Azatyan, Armine Minasyan, Naira Gyulazyan
フォーマット:	論文
言語:	英語
出版事項:	The Journal of Infection in Developing Countries 2024-05-01
主題:	Chronic HCV infection hepatocellular carcinoma liver cirrhosis direct-acting antiviral agents
オンライン･アクセス:	https://jidc.org/index.php/journal/article/view/18410